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Abstract
Today insulin is used not only in medicine in the treatment of diabetes but also in sport 
as a doping agent and for criminal purposes. Suicides and homicides with insulin maybe 
are not so common, but are seen in the routine medicolegal and toxicological-clinical 
practice. Despite the often quite clear circumstances of death and a well-established 
mechanism of action of insulin and its analogs, it is difficult to analytically confirm its 
excessive exogenous administration in postmortem biological material. There are no uni-
form international standards of conduct in such cases, both at the stage of the material 
sampling during autopsy and forensic laboratory analysis and the final interpretation of 
the obtained results. The aim of the study is to present the current state of basic knowl-
edge about nonmedical use of insulin, with particular emphasis on the possibility of post-
mortem diagnosis. The study also highlighted the little known clinical problem of insulin 
abuse for recreational purposes.
Keywords: overdose, homicide-suicide, postmortem diagnostics, thanatobiochemistry, 
medicolegal autopsy, forensic histopathology
1. Introduction
Insulin is a potent anabolic polypeptide hormone which stimulates the uptake and storage of 
carbohydrates, fatty acids, and amino acids into glycogen, fat, and protein, respectively [1]. 
The typical physiological effect of its action is hypoglycemia (reduction in blood glucose). The 
result of a casual or intentional overdose of insulin is a hypoglycemic coma and in extreme 
cases even death of the user. Today it is used not only in medicine in the treatment of diabetic 
patients but also in competitive sport as a common doping agent for body building [2, 3] and 
for different criminal purposes [4–8]. Suicides and homicides with insulin maybe are not so 
common, but are seen in the routine medicolegal and toxicological-clinical practice. The first 
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documented case of murder by insulin is dated to the year 1957 (Kenneth Barlow case) [9]. 
Vincent Marks in his review has analyzed case histories of 66 people alleged or proven to 
have been poisoned by insulin (murders, manslaughters, attempted murders, Munchausen-
by-proxy cases) [7].
Of course, some insulin overdoses are accidental and associated with incorrect dosage of the drug 
by the patient [10, 11]. Most of these cases are not clinically serious. It seems, however, that the 
risk of intentional (suicidal) insulin overdose in patients with diabetes of both types (1 and 2) is 
underestimated. The population-based study of suicide victims in Northern Finland performed 
by Löfman et al. revealed that 3.1% of all suicide victims had diabetes (34.6% type 1 and 65.4% 
type 2) [12]. In victims with type 1 diabetes, insulin as a suicide method covered half of the self-
poisoning cases, while the proportion in type 2 diabetes was 13%. It is known that the risk of 
depression and attempted suicide is higher in patients with chronic diseases, including diabetes, 
so physicians who treat diabetic patients should evaluate co-occurring depression and substance 
abuse, both of which are major risk factors of suicide [13, 14].
The aim of the author is to present the current state of basic knowledge about the nonmedi-
cal use of insulin, with particular emphasis on the possibility of postmortem diagnosis. The 
study also highlighted the little known, rare clinical problem of insulin abuse for recreational 
purposes.
2. Case reports
In order to illustrate the abovementioned problems, I present two typical cases from rou-
tine medicolegal practice of the Department of Forensic Medicine and Forensic Toxicology 
in Katowice, School of Medicine in Katowice, Medical University of Silesia, Poland [15, 16].
2.1. Suicide
A 44-year-old nondiabetic man was found dead lying on the bed in his flat. Near the body, 
an ampoule and almost empty syringe were found and taken for further analysis. Two days 
earlier, the man had called his wife and said that he is going to commit suicide. The forensic 
autopsy did not reveal the cause of death. The initial stage of putrefaction, blood fluidity, 
acute blood stagnation (hyperemia) in the internal organs, and two supravital point wounds 
on the right thigh, which might have been injection sites, were found. Histopathological find-
ings in the main internal organs were the following: brain, hyperemia with numerous pete-
chiae, and edema; heart, adipositas, medium grade of atherosclerosis of the coronary arteries, 
and local fragmentation of muscle fibers; and lungs, hyperemia with local hemorrhages into 
alveoli and edema. Additional histochemical staining (Periodic Acid-Schiff, PAS) disclosed 
low amounts of glycogen in the liver (Figure 1). The standard toxicological analysis disclosed 
no evidence of drug abuse or alcohol, so due to the suspicion of suicide by insulin injection, a 
directed analysis with immunoradiometric assay (IRMA Kit Immunotech), routinely used for 
the in vitro determination of insulin in human serum and plasma, was conducted. It revealed 
a high insulin concentration level—24.42 μIU/ml in the vitreous humor (measuring range, 
0.5–300 μIU/ml; the norm for serum, <22 μIU/ml)—and the presence of insulin in the material 
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secured at the crime scene (in the syringe, 1853.91 μIU/ml). All these results (information from 
the prosecutor about the crime scene, results of medicolegal autopsy, results of histopatho-
logical and toxicological studies) clinched the thesis of insulin overdose.
Figure 1. Low amounts of glycogen in the liver—50% of control sections taken during autopsy of sudden traumatic 
death victims.
Figure 2. Empty packages after insulin, NovoMix 30 Penfill (a mixture of fast and long-acting insulin analogue), revealed 
in the apartment of victim. Needles can be analyzed by forensic geneticists for the presence of DNA mixture of the victim 
and murderer in the case of homicide-suicide death.
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2.2. Homicide-suicide
According to the information of the Prosecutor’s Office, a 63-year-old man was supposed to 
kill his wife and dog and then commit suicide. Such situation in forensic medicine is called 
homicide-suicide or dyadic death. In the apartment a farewell letter and empty packages 
after insulin, NovoMix 30 Penfill (a mixture of fast and long-acting insulin analogue), were 
revealed (Figure 2). External medicolegal examination and forensic autopsies carried out at 
the Department of Forensic Medicine and Forensic Toxicology of the Medical University of 
Silesia in Katowice did not explain the cause of death. However, potential injection sites on 
the thighs and the shoulder of woman were revealed (Figure 3). Different biological materi-
als for additional tests—biochemical, chemical-toxicological, and histopathological and for 
forensic genetics—were taken. Due to the inability to quickly determine insulin level in body 
fluids and the site of injection using the reference chromatographic methods [17–20], the 
determination of this hormone was ordered to two clinical diagnostic laboratories (by chemi-
luminometric and immunoradiometric methods). In addition, C-peptide (short 31-amino-acid 
Figure 3. Numerous supravital point wounds and surrounding bruises on the thighs—potential insulin injection sites.
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polypeptide that connects insulin’s A-chain to its B-chain in the endogenous proinsulin mol-
ecule), glycated hemoglobin (HbA1c, a form of hemoglobin that is measured primarily to 
identify the 2- to 3-month average plasma glucose concentration), glucose, and lactate (it is 
known that one mole of glucose during the process of glycolysis produces two moles of lac-
tate) were ordered. Incomplete, difficult-to-interpret results were obtained. In addition, a suc-
cessful attempt of immunohistochemical (IHC) detection of insulin in samples taken from the 
injection sites was made (Figure 4) [21, 22]. The results of the tests carried out in the above-
mentioned clinical laboratories confirmed our previous experience with the low usefulness of 
insulin determinations in the autopsy hemolyzed blood specimens (article in press).
3. Postmortem diagnostics of fatal insulin poisoning
3.1. Medicolegal autopsy
A classic postmortem macroscopic examination of the corpses (forensic autopsy) usually does 
not explain the cause and mechanism of death [23, 24]. Typically a feature of acute cardio-
respiratory failure and nonspecific lesions related to the age of victim (e.g., atherosclerotic 
changes in vessels) can be found. For this reason, additional laboratory tests are necessary 
in each case. In addition to routinely collected sections from internal organs and body fluids 
(blood and urine), it is worth to take at least the sample of vitreous humor (VH) and the 
samples from potential injection sites for both histopathological and directed toxicological 
analyses.
3.2. Forensic histopathology and immunohistochemistry
A detailed histological examination of all internal organs, especially of the pancreas and 
liver, aiming at detection of insulinoma (tumor of the pancreas that is derived from β cells 
and secretes insulin) and morphological symptoms of hypoglycemia, respectively, should 
Figure 4. Positive immunohistochemical (IHC) detection of insulin in the subcutaneous tissue around needle tracts 
between adipocytes (right) and control section from distant area of the skin with no reaction (left).
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be always performed by experienced pathologist. The content of glycogen (multibranched 
polysaccharide of glucose that serves as a form of main energy storage) in the liver may be 
evaluated by the Periodic Acid-Schiff (PAS) or Best’s Carmine staining. Its low amounts can 
indirectly confirm insulin overdose, as it was presented in the first case [15]. Another use-
ful option is to perform IHC staining for the presence of insulin at the injection site. It is not 
necessary to buy special antibodies. These routinely used in clinical histopathology can be 
successfully used for this purpose, as we demonstrated in the second case [16].
3.3. Forensic toxicology and thanatobiochemistry (postmortem biochemistry)
In routine forensic practice, usually antemortem blood samples of the victim, who sometimes 
is hospitalized before the death, are unavailable for forensic toxicologists, so they can ana-
lyze only postmortem biological material taken during autopsy and nonbiological specimens 
revealed at the crime scene, like syringes, ampoules, vials, or remnants of the infusion solu-
tion and tubings [24–26].
What is important from the medicolegal point of view is that the interpretation of insulin lev-
els in the postmortem biological material is difficult and still in doubt [27–31]. The number of 
published papers dealing with this problem is relatively low. The time of survival after insu-
lin injection depends on many different factors: type of insulin (differentiated onset of action 
and insulin half-life), method of administration (injection or insulin infusion pump), anatomi-
cal localization of injection sites on the body (different rate of absorption), etc. [32]. It certainly 
influences the insulin levels detected in the postmortem biological material. Unfortunately, 
in the forensic practice, investigators usually do not know that time, because the cadavers not 
infrequently are found after a long time since death at an advanced stage of late postmortem 
changes, for example, when the victim lived alone or the killer committed suicide [21].
Additionally, insulin determination in postmortem blood has a low diagnostic and testimo-
nial value, mainly because of ongoing thanatochemical processes of autolysis and putrefac-
tion [8, 24]. The main barrier that prevents receiving correct and trustworthy results of insulin 
determinations in postmortem blood with radioimmunological methods is the blood hemo-
lysis (rupturing of red blood cells and the release of their contents into surrounding plasma). 
This fact was confirmed in the literature and by our own studies performed in the Department 
of Forensic Medicine and Forensic Toxicology in Katowice [32, 33].
Fortunately, insulin crosses the blood-retinal barrier and may be identified in the VH, which 
is generally very valuable alternative material for many different chemical-toxicological anal-
yses [34, 35]. The advantage of this material is that it is easy to obtain during typical forensic 
autopsy. Another advantage is anatomical isolation, useful especially in the case of advanced 
autolytic and putrefactive changes in corpore. It has also a very low cell count, so there is a 
small postmortem metabolism of glucose and other substances by surviving cells.
In 2011 Thevis et al. have published the first successful mass spectrometry-based analysis 
of postmortem material (VH) related to an insulin poisoning case [17]. The natural levels of 
insulin in vitreous humor determined by the authors were below the liquid chromatography–
tandem mass spectrometry (LC-MS/MS) limit of detection. LC-MS/MS is modern advanced 
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instrumental method widely used in analytical chemistry. This was a significant advance in 
postmortem biochemistry. Our own experience shows that in cases where suicide by insulin 
poisoning is suspected, determination of its concentration in the vitreous humor and nonbio-
logical material using the immunoradiometric assay (IRMA) gives the opportunity, similarly 
as the LC-MS/MS analysis, of objective confirmation of the poisoning, so both methods can be 
used in forensic practice [32].
In our department, we have analyzed material consisted of 93 samples of vitreous humor 
taken during forensic autopsies. Analysis revealed that in 86 vitreous humor samples (92.5%), 
the concentration of insulin, determined with IRMA, was below the limit of detection of this 
method (below 0.5 μIU/ml). The concentration of insulin in vitreous humor was determined 
only in seven cases (range of results, 1.42–24.42 μIU/ml). We have described above one of 
these cases, where insulin was used to commit suicide [15].
The IRMA method is known as sensitive, specific, and relatively cheap in comparison to mod-
ern methods, but it requires adequate apparatus for the measurement of radioactivity and 
some experience in its interpretation. It is worth knowing that the studies on insulin determi-
nation using antibody-radiolabeled antigen reaction in the late 1950s were the beginning of a 
new medical discipline—radioimmunology [36]. Until the introduction of radioimmunoassay 
(RIA), death caused by insulin overdose was extremely difficult to prove [4]. In turn, the huge 
advantage of modern chromatographic methods (LC-MS/MS) is the possibility of differentia-
tion between different types of insulins (human or animal insulin and their synthetic deriva-
tives/analogues). In 2015, Palmiere et al. have presented preliminary results of postmortem 
determination of insulin using chemiluminescence enzyme immunoassay (CLEIA). Their 
conclusion was that the analysis of vitreous humor with CLEIA may provide suitable data, 
similar to analysis with LC-MS/MS and immunoradiometric assay, to support the hypothesis 
of insulin overdose [37].
Regardless of the method used in toxicological investigation, an analytically confirmed higher 
level of insulin in the vitreous humor plays an important and even a decisive role in structur-
ing the final medicolegal opinion about the cause of death. This is the reason why the vitreous 
humor should be routinely collected and analyzed during forensic autopsy in every case with 
an “insulin” background [29, 37].
3.4. Forensic molecular biology
An interesting observation, so far unused in the forensic practice, is an increase in the expres-
sion of certain genes stimulated by insulin, especially in hyperinsulinemic conditions. This is 
a potentially promising area for further research. An example might be the changes of neu-
ropeptide Y (NPY) gene expression and its release during hypoglycemic stress. Han et al. 
found that subcutaneous insulin injection produced an immediate increase in plasma NPY 
immunoreactivity and delayed increases in adrenal and neuronal NPY mRNA and adrenal 
NPY immunoreactivity in rats [38]. They have concluded that these results suggest that NPY 
may play a role in insulin-induced hypertension. Another example can be increased vascular 
resistance in the equine digit and overexpression of endothelin-1 (ET-1) in the laminar tissue 
due to the short-term hyperinsulinemia [39].
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4. Clinical toxicology of insulin poisoning
An overdose of insulin is a potential life-threatening condition and requires urgent medical 
attention [40–46]. The clinical manifestations of hypoglycemia occur when the blood glucose 
level is less than 2.2–2.8 mmol/l (40–50 mg%). Symptomatology includes two groups of symp-
toms. The first one is caused by stimulation of the autonomic nervous system and includes 
profuse sweating, anxiety, tremor, and hunger. The second one is caused by progressive dys-
function of the central nervous system (CNS) due to neuroglycopenia and includes nausea, 
headache, dizziness, blurred vision, abnormal intellectual processes, behavioral disturbances, 
and finally loss of consciousness, convulsions, and death.
The most optimal place of the treatment is clinical toxicology ward, but patients who are over-
dosed with insulin can be also treated in typical intensive care units or in less serious cases—
in general internal wards. To differentiate endogenous and exogenous insulin overdose, 
usually insulin/C-peptide [mol/mol] ratio is used, both in clinical and forensic settings [47]. 
Physiologically for every molecule of insulin formed, a corresponding molecule of C-peptide 
is formed. If the above-described ratio is >1, it indicates exogenous origin of insulin (as a result 
of accident, suicide, or homicide). However, it should be remembered that C-peptide is very 
unstable in postmortem blood [4].
Treatment of hypoglycemia is initially based on the securing of basic vital functions (breathing 
and circulation). Subsequently, infusions of glucose solution adjusted to the current blood glucose 
levels are used. Depending on the clinical situation, other drugs are administered s.c. or i.v. (e.g., 
glucagon which is a glycogenolysis stimulator), as it was presented in above-cited clinical emer-
gency case reports. In the past such specific methods of treatment and management have been 
reported as excision of insulin injection site or the use of artificial pancreas [48–50]. Assessment 
of patient prognosis relies on clinical findings. According to the results of prospective study of 
Mégarbane et al., the observed plasma insulin EC50 (the concentration which induces a response 
halfway between the baseline and maximum after a specified exposure time) is 46 mIU/l [51].
Tsujimoto et al. have described rare case of rapid onset reversible glycogen storage hepatomegaly 
caused by suicidal administration of a massive dose of long-acting insulin glargine and subse-
quent supplementation with large doses of glucose in a 41-year-old type-2 diabetic patient [52]. 
Supravital liver biopsy revealed hepatocytic glycogen deposition with edematous degeneration. 
PAS staining revealed many PAS-positive granules containing glycogen. The hepatic computed 
tomography (CT) attenuation was 83.7 Hounsfield units (HU), being markedly higher than the 
splenic attenuation (49.5 HU), which indicated pathology of the liver. Such situation (initially 
higher level of hepatocytic glycogen deposition) must be considered not only by clinicians but 
also by forensic histopathologist during examination of the insulin fatal poisoning victim’s liver.
5. Insulin abuse
An interesting, still not fully explained phenomenon, connecting toxicology, diabetology, and 
psychiatry, is abuse of insulin as a psychoactive substance. Intentional abuse of insulin is quite 
rare, but not exceptional. Pudlo et al. described an insulin abuser—the 58-year-old patient who 
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injected himself with overdoses of insulin or consumed considerable amounts of pure sugar to 
increase its dose [53]. No other reason for his insulin abuse was found than pleasure seeking. 
According to the patient, he felt “pleasure” after insulin. Sheehy has counted 55 cases of patients 
developing hypoglycemic episodes by intentional insulin injecting [54]. Sometimes people suf-
fering from Munchausen syndrome can also apply themselves an excessive dose of the drug 
to cause factitious hypoglycemia and get to the hospital [7, 55]. In the case of Munchausen 
syndrome by proxy (per procuram), the victims may be the relatives, most often children [56].
6. Conclusions
Despite the often quite clear circumstances of death and a well-established mechanism of 
action of insulin and its analogues, it is difficult to analytically confirm its excessive exog-
enous administration in postmortem biological material [8]. There are no uniform standards 
of conduct in this type of cases, both at the stage of the material sampling and laboratory 
analysis and in the interpretation of the obtained results.
If insulin overdose is suspected, it is necessary to take the different biological material dur-
ing autopsy for further testing and to cautiously interpret its results [7]. It seems necessary to 
immediately develop a unified international standards/algorithm of conduct, similar to those 
used in clinical medicine, including the determination of insulin level and other parameters 
of carbohydrate metabolism in the postmortem biological material, taking into account all 
above-described possibilities and limitations of laboratory analysis [57–59].
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